Inhibitory effects of Terminalia chebula extract on glycation and endothelial cell adhesion

Planta Medica

Volumn 77, Issue 10, 2011, Pages 1060-1067

  Lee, Hyun Sun ^a   Cho, Hong Yon ^a   Park, Kuen Woo ^a   Kim, In Hwan ^a   Kim, Jong Tak ^b   Nam, Mi Hyun ^a   Lee, Kwang Won ^a  

^a Korea University   (South Korea)

^b KOCAT Inc   (South Korea)

Author keywords

advanced glycation end products; antioxidant; Combretaceae; diabetic complications; lens crystalline; Terminalia chebula Retz.

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; CHEBULIC ACID; REACTIVE OXYGEN METABOLITE; TERMINALIA CHEBULA EXTRACT; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; ENDOTHELIUM CELL; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LENS CAPSULE; MONOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANTIOXIDANTS; CELL ADHESION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LENS, CRYSTALLINE; MONOCYTES; PLANT EXTRACTS; PLANTS, MEDICINAL; TERMINALIA; UMBILICAL VEINS;

COMBRETACEAE; TERMINALIA CHEBULA;

EID: 79959992844     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1270748     Document Type: Article

References (33)

1. Morello C M. Etiology and natural history of di (Pubitemid 350202222)
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 813-820 (Pubitemid 34000785)
3. Reddy V P., Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov Today 2006 11 646-654
4. Lingelbach L B., Mitchell A E., Rucker R B., McDonald R B. Accumulation of advanced glycation endproducts in aging male Fischer 344 rats during long-term feeding of various dietary carbohydrates. J Nutr 2000 130 1247-1255 (Pubitemid 30233275)
5. Deelman L, Sharma K. Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens 2009 18 85-90
6. Rao N, Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med 2006 6 17-22
7. Ishtiaq M, Hanif W, Khan M A., Ashraf M, Butt A M. An ethnomedicinal survey and documentation of important medicinal folklore food phytonims of flora of Samahni valley, (Azad Kashmir) Pakistan. Pakistan J Biol Sci 2007 10 2241-2256 (Pubitemid 47056160)
8. Dutta B K., Rahman I, Das T K. Antifungal activity of Indian plant extracts: Antimyzetische Aktivitt indischer Pflanzenextrakte. Mycoses 1998 41 535-536
9. Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell R R. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int J Antimicrob Agents 2001 18 85-88 (Pubitemid 32703873)
10. Prasad L, Khan T H., Jahangir T, Sultana S. Abrogation of DEN/Fe-NTA induced carcinogenic response, oxidative damage and subsequent cell proliferation response by Terminalia chebula in kidney of Wistar rats. Pharmazie 2007 62 790-797 (Pubitemid 47610499)
11. Senthilkumar G P., Subramanian S P. Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats. J Appl Biomed 2006 6 17
12. Murali Y K., Anand P, Tandon V, Singh R, Chandra R, Murthy P S. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats. Exp Clin Endocrinol Diabetes 2007 115 641-646 (Pubitemid 350220403)
13. Lee H S., Jung S H., Yun B S., Lee K W. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch Toxicol 2007 81 211-218
14. Ahn M J., Kim C Y., Lee J S., Kim T G., Kim S H., Lee C K., Lee B B., Shin C G., Huh H, Kim J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med 2002 68 457-459 (Pubitemid 34606693)
15. Lee H S., Nam H W., Kyoung H K., Lee H, Jun W, Lee K W. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol Pharm Bull 2005 28 1639-1644 (Pubitemid 41324124)
16. Choi S Y., Jung S H., Lee H S., Park K W., Yun B S., Lee K W. Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract. Phytother Res 2008 22 323-329
17. Ghiselli A, Serafini M, Maiani G, Azzini E, Ferro-Luzzi A. A fluorescence-based method for measuring total plasma antioxidant capability. Free Radic Biol Med 1995 18 29-36
18. Yildiz G, Demiryrek A T., Sahin-Erdemli I, Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol 1998 124 905-910 (Pubitemid 28312824)
19. Courderot-Masuyer C, Dalloz F, Maupoil V, Rochette L. Antioxidant properties of aminoguanidine. Fundam Clin Pharmacol 1999 13 535-540
20. Thornalley P J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 2003 419 31-40 (Pubitemid 37279141)
21. Tyagi N, Ovechkin A V., Lominadze D, Moshal K S., Tyagi S C. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J Cell Biochem 2006 98 1150-1162 (Pubitemid 44131429)
22. Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway. Life Sci 2004 75 1333-1341 (Pubitemid 38845032)
23. Bustos P, Duffau C, Pacheco C, Ulloa N. [beta]-Sitosterol modulation of monocyte-endothelial cell interaction: a comparison to female hormones. Maturitas 2008 60 202-208
24. Lee K W., Mossine V, Ortwerth B J. The relative ability of glucose and ascorbate to glycate and crosslink lens proteins in vitro. Exp Eye Res 1998 67 95-104 (Pubitemid 28364818)
25. Webster J, Wilke M, Stahl P, Kientsch-Engel R, Munch G. Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases. Z Gerontol Geriatr 2005 38 347-353 (Pubitemid 41558653)
26. Laakso M, Kuusisto J. Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 1996 28 415-418 (Pubitemid 26380000)
27. Cohen J D. Overview of physiology, vascular biology, and mechanisms of hypertension. J Manag Care Pharm 2007 13 S6-S8 (Pubitemid 47162408)
28. Calcutt N A., Cooper M E., Kern T S., Schmidt A M. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 2009 8 417-430
29. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995 46 223-234
30. Lee H S., Koo Y C., Suh H J., Kim K Y., Lee K W. Preventive effects of chebulic acid isolated from Termialia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J Ethnopharmacol 2010 131 567-574
31. Juang L J., Sheu S J., Li T C. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep Sci 2004 27 718-724
32. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 2008 196 9-21
33. Jay D, Hitomi H, Griendling K K. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 2006 40 183-192 (Pubitemid 43069343)